Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds JP Morgan Upgrades Ambev to Overweight

JP Morgan Upgrades Ambev to Overweight

JP Morgan analyst Lucas Ferreira upgrades Ambev (NYSE:ABEV) from Neutral to Overweight.

byBenzinga Newsdesk

July 13, 2022

1 minute read

JP Morgan analyst Lucas Ferreira upgrades Ambev (NYSE:ABEV) from Neutral to Overweight.

News

Acumen Pharmaceuticals Secures $50.0M Credit Facility with K2 HealthVentures

By Benzinga Newsdesk

Today, 7:08 AM

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) ("Acumen" or the "Company"), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers

ABOS

Analyst Ratings

Expert Ratings for Invitation Homes

By Benzinga Insights

June 26, 11:00 AM

Analysts have provided the following ratings for Invitation Homes (NYSE:INVH) within the last quarter: Bullish Somewhat Bullish Indifferent…

INVH

Boeing 737 Max 9 Crisis Deepens: United Airlines Discovers Loose Bolts

By Benzinga Neuro

January 8, 8:50 PM

In a recent development, United Airlines Holdings Inc (NASDAQ:UAL) has uncovered loose bolts in several grounded 737 MAX…

ALK

Freightos, A Leading, Vendor-Neutral Booking And Payment Platform For International Freight, Lists On Nasdaq Following Merger With Special Purpose Acquisition Company, Gesher I Acquisition Corp.

By Benzinga Newsdesk

January 26, 11:06 AM

Freightos facilitates smooth supply chains, following two years of rampant volatility

CRGO

JP Morgan Upgrades Ambev to Overweight

Related Posts

Acumen Pharmaceuticals Secures $50.0M Credit Facility with K2 HealthVentures

Expert Ratings for Invitation Homes

Boeing 737 Max 9 Crisis Deepens: United Airlines Discovers Loose Bolts

Freightos, A Leading, Vendor-Neutral Booking And Payment Platform For International Freight, Lists On Nasdaq Following Merger With Special Purpose Acquisition Company, Gesher I Acquisition Corp.